Astria Therapeutics, Inc. Accumulated Other Comprehensive Income
Astria Therapeutics, Inc. had Accumulated Other Comprehensive Income of $56.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2025-11-12
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $56.00K.
- 2025-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$16.00K.
- 2025-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $60.00K.
- 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $163.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2025-09-30 | $56.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | -$16.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $60.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $163.00K 10-Q · filed 2025-11-12 |
| 2024-09-30 | $331.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | -$45.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | -$14.00K 10-Q · filed 2024-05-09 |
| 2023-03-31 | -$4.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$79.00K 10-K · filed 2024-03-04 |
| 2022-09-30 | -$215.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$186.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$53.00K 10-Q · filed 2022-05-12 |
| 2020-06-30 | $1.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$15.00K 10-Q · filed 2020-05-12 |
| 2019-06-30 | $1.00K 10-Q · filed 2019-08-08 |
| 2018-12-31 | -$4.00K 10-K · filed 2020-03-10 |
| 2018-09-30 | -$5.00K 10-Q · filed 2018-11-13 |
| 2016-12-31 | -$4.00K 10-K · filed 2018-03-15 |
| 2016-09-30 | -$3.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $8.00K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $14.00K 10-Q · filed 2016-05-12 |